Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125608891 | 12560889 | 1 | I | 20160712 | 20160715 | 20160715 | EXP | CA-AMGEN-CANSP2016090625 | AMGEN | 0.00 | F | Y | 0.00000 | 20160715 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125608891 | 12560889 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | U | 103795 | 50 | MG | UNKNOWN FORMULATION | /wk | |||||
| 125608891 | 12560889 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 8 MG, UNK | 0 | 8 | MG | ||||||||
| 125608891 | 12560889 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | 40 MG, Q2WK | 0 | 40 | MG | QOW | |||||||
| 125608891 | 12560889 | 4 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 20 MG, UNK | 0 | 20 | MG | TABLET | |||||||
| 125608891 | 12560889 | 5 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 20 MG, QWK | 0 | 20 | MG | /wk | |||||||
| 125608891 | 12560889 | 6 | SS | ORENCIA | ABATACEPT | 1 | Subcutaneous | 125 MG, QWK | 0 | 125 | MG | /wk | |||||||
| 125608891 | 12560889 | 7 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | 1000 MG, UNK | 0 | 1000 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125608891 | 12560889 | 1 | Rheumatoid arthritis |
| 125608891 | 12560889 | 2 | Product used for unknown indication |
| 125608891 | 12560889 | 3 | Product used for unknown indication |
| 125608891 | 12560889 | 4 | Product used for unknown indication |
| 125608891 | 12560889 | 5 | Product used for unknown indication |
| 125608891 | 12560889 | 6 | Product used for unknown indication |
| 125608891 | 12560889 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125608891 | 12560889 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125608891 | 12560889 | Drug effect decreased | |
| 125608891 | 12560889 | Drug ineffective | |
| 125608891 | 12560889 | Hypersensitivity | |
| 125608891 | 12560889 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |